Kimball Electronics is navigating a critical strategic transition, shifting its business model from a cyclical Electronics Manufacturing Services (EMS) provider toward a higher-margin medical Contract Manufacturing Organization (CMO) platform. While the medical segment is showing robust momentum (growing 10.2% sequentially in Q3 FY2026 and representing 30% of total sales), the company faces near-term headwinds. These include persistent cyclical weakness in its core automotive and industrial end-markets, a third consecutive year of declining top-line revenue, and expected gross margin pressure of 40-50 basis points in FY2027 due to the ramp-up of its new 300,000-square-foot Indianapolis facility. Given these balanced dynamics of long-term margin expansion potential versus near-term execution risks and macro headwinds, a Hold recommendation is warranted.